glp-1 drugs approved for weight loss GLP1 Drug Use Has Soared Costing Billions GLP-1s for Weight Loss: What
Description
Effects of PCSK1 Genetic Variants on Obesity among Thai Children and Their Family Members: In Relation to Health Risk, and Biochemical and Anthropometric Parameters. The Southeast Asian Journal of Tropical Medicine and Public Health, vol
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Patients may experience side effects such as gastrointestinal discomfort, and certain populations, such as those with pancreatitis or severe gastrointestinal disorders, may not be suitable candidates

P., Obesity, & Risk, C

DOI: 10.2337/db10-0474 Shaefer CF Jr et al (2015): User's guide to mechanism of action and clinical use of GLP-1 receptor agonists

The one clear fact was that patients with duodenal ulcers gave an exaggerated secretory response to histamine, the basis of a diagnostic test' (Black)
